Imatinib

Imatinib, a potent medication belonging to the Tyrosine Kinase Inhibitor class, effectively blocks several key proteins involved in cancer progression, including BCR-ABL, PDGFR, and c-Kit. By specifically targeting these proteins, Imatinib disrupts the signaling pathways necessary for abnormal cell proliferation and survival. Additionally, Imatinib competes with ATP (Adenosine triphosphate) by binding to the ATP-binding pocket of these proteins, preventing ATP from activating them. This inhibition prevents tumor growth and spread, making Imatinib a crucial therapy in the treatment of certain leukemias and other cancers.

Administration

This oral medication (pill) should be taken once a day, preferably with food to avoid nausea and vomiting.

Potential Side Effects Management


• Infection Risk: Given treatments’ intensity, reduced white blood cell counts heighten infection risks, necessitating vigilance and timely medical intervention. If you have a fever over 38.3°C, you should advise your medical team or go to the emergency department.
• Bruising and Bleeding: Reduced platelets due to treatment can lead to easy bruising, nosebleeds, or blood in urine/stool. Platelet transfusion might be necessary.
• Nausea and Vomiting: Managing these side effects can significantly impact quality of life during treatment.
• Stomach Pain: Pain, bloating, indigestion, or discomfort in the abdomen. Your doctor can prescribe medications to alleviate these symptoms.
• Diarrhea: Increased bowel activity.
• Constipation: inability to pass stools as often as usual. Management includes drinking a lot of fluids, increasing fiber consumption, light exercise, and in severe cases, laxatives may be prescribed.
• Fatigue: This treatment may cause fatigue or weakness, which can impact daily activities.
• Fluid build-up: Weight gain or swelling; improves after treatment.
• Liver Problems: This treatment can lead to liver injury, characterized by elevated levels of liver enzymes (transaminases) and bilirubin in the blood. Close monitoring of liver function through regular blood tests is essential.
• Rash: Rash symptoms typically start within 2 to 4 weeks of treatment initiation but may also appear later, even after a few months.
• Headache, Muscle, Bone or Joint Pain: Pain in head, bones, muscles or joints may arise; notify your doctor for pain relief, especially if persistent.
• Respiratory and chest-related disorders: Coughing, sore throat and throat pain.

When to Seek Medical Attention

• Infection Risk: Given treatments’ intensity, reduced white blood cell counts heighten infection risks, necessitating vigilance and timely medical intervention. If you have a fever over 38.3°C, you should advise your medical team or go to the emergency department.
• Bruising and Bleeding: Reduced platelets due to treatment can lead to easy bruising, nosebleeds, or blood in urine/stool. Platelet transfusion might be necessary.
• Nausea and Vomiting: Managing these side effects can significantly impact quality of life during treatment.
• Stomach Pain: Pain, bloating, indigestion, or discomfort in the abdomen. Your doctor can prescribe medications to alleviate these symptoms.
• Diarrhea: Increased bowel activity.
• Constipation: inability to pass stools as often as usual. Management includes drinking a lot of fluids, increasing fiber consumption, light exercise, and in severe cases, laxatives may be prescribed.
• Fatigue: This treatment may cause fatigue or weakness, which can impact daily activities.
• Fluid build-up: Weight gain or swelling; improves after treatment.
• Liver Problems: This treatment can lead to liver injury, characterized by elevated levels of liver enzymes (transaminases) and bilirubin in the blood. Close monitoring of liver function through regular blood tests is essential.
• Rash: Rash symptoms typically start within 2 to 4 weeks of treatment initiation but may also appear later, even after a few months.
• Headache, Muscle, Bone or Joint Pain: Pain in head, bones, muscles or joints may arise; notify your doctor for pain relief, especially if persistent.
• Respiratory and chest-related disorders: Coughing, sore throat and throat pain.

Scroll to Top